Skip to main content

High-Throughput Screening for Allosteric Modulators of GPCRs

  • Protocol
G Protein-Coupled Receptors in Drug Discovery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1335))

Abstract

The continued evolution of our understanding of G protein-coupled receptor (GPCR) signaling has revealed new opportunities for drug discovery. Specifically, biased agonism at GPCRs and allosteric modulation of GPCRs both represent emerging areas of GPCR biology that hold promise for the development of novel GPCR-targeted therapeutics that may provide greater therapeutic efficacy and/or improved side-effect profiles. To obtain initial chemical leads, high-throughput screening (HTS) of a large compound library for the desired activity is often deployed during the early stages of a discovery program. The identification of allosteric modulators, in particular, poses significant challenges for HTS. We describe several HTS protocols designed for the identification of GPCR ligands, with a particular focus on the identification of allosteric modulators.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Filmore D (2004) It’s a GPCR world. Modern Drug Discov (Am Chem Soc) 7:24–28

    Google Scholar 

  2. Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996

    Article  CAS  PubMed  Google Scholar 

  3. Kostenis E, Waelbroeck M, Milligan G (2005) Techniques: Promiscuous Gα proteins in basic research and drug discovery. Trends Pharmacol Sci 26:595–602

    Article  CAS  PubMed  Google Scholar 

  4. Christopoulos A, Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323–374

    Article  CAS  PubMed  Google Scholar 

  5. May LT, Leach K, Sexton PM et al (2007) Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 47:1–51

    Article  CAS  PubMed  Google Scholar 

  6. Zhang JH, Chung TD, Oldenberg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67–73

    Article  PubMed  Google Scholar 

  7. Burford NT, Bertekap RL Jr, Banks M et al (2011) Hit identification practices for positive allosteric modulators of G protein-coupled receptors: The need for multiple-mode screening approaches in dynamic Ca2+ flux assays. Int Drug Discov 6(1):28–33

    Google Scholar 

  8. Sharma S, Rodriguez AL, Conn PJ et al (2008) Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold. Bioorg Med Chem Lett 18:4098–4101

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Jacoby E, Bouhelal R, Gerspacher M et al (2006) The 7 TM G-protein-coupled receptor target family. ChemMedChem 1:761–782

    Article  PubMed  Google Scholar 

  10. Rodriguez AL, Grier MD, Jones CK et al (2010) Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity an in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity. Mol Pharmacol 78:1105–1123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Noblin D, Bertekap RL Jr, Burford NT et al (2012) Development of a high-throughput calcium flux assay for identification of all ligand types including positive, negative, and silent allosteric modulators for G protein-coupled receptors. Assay Drug Dev Technol 10:457–467

    Article  CAS  PubMed  Google Scholar 

  12. Burford NT, Watson J, Bertekap R et al (2011) Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Biochem Pharmacol 81:691–702

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Alt .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this protocol

Cite this protocol

Bertekap, R.L., Burford, N.T., Li, Z., Alt, A. (2015). High-Throughput Screening for Allosteric Modulators of GPCRs. In: Filizola, M. (eds) G Protein-Coupled Receptors in Drug Discovery. Methods in Molecular Biology, vol 1335. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2914-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2914-6_15

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2913-9

  • Online ISBN: 978-1-4939-2914-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics